Skip to main content
Premium Trial:

Request an Annual Quote

Benjamin Bulkley, Frank Witney, Lynn Busteed

Benjamin Bulkley, former senior vice president of global commercial operations for Invitrogen, has been named COO of Allscripts Healthcare Solutions, an electronic health records software manufacturer.
 

 
Transgenomic has named Frank Witney to its board of directors.
 
Witney is president, CEO and director of Panomics, and is a director of Applied Precision. He also has been president of PerkinElmer’s drug-discovery business and was COO of Packard Biosciences.
 

 
Enigma Diagnostics this week named Lynn Busteed to be its new CEO and director. Busteed was previously vice president for corporate development at Focus Diagnostics and was senior director of business development and strategic planning at Celera Genomics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.